PresentationsDeveloping Predictive ML Models to Inform TPD Lead Optimization By AldenMC Production / April 3, 2023
PresentationsFirst Targeted Protein Degradation for Hematological Malignancies By AldenMC Production / April 3, 2023
PresentationsTargeted Protein Degradation of BTK for Hematological Malignancies and Autoimmune Disease: Preclinical and Initial Phase 1a PK/PD Data for NX-5948 By AldenMC Production / March 15, 2023
PresentationsUtilizing DEL as a Primary Discovery Engine for Targeted Protein Modulation By AldenMC Production / February 8, 2023
PresentationsMolecular Property Prediction Using Machine Learning By AldenMC Production / December 6, 2022
PresentationsChemistry @Nurix: Protein Modulation for Drug Discovery By AldenMC Production / November 10, 2022
PresentationsNX-1607, a Small Molecule Inhibitor of the CBL-B E3 Ubiquitin Ligase, Promotes T and NK Cell Activation and Enhances NK-mediated ADCC in a Mouse Lymphoma Tumor Model By AldenMC Production / November 10, 2022
PresentationsThe CBL-B Inhibitor, NX-0255, Improves Human Drug Enhanced Tumor Infiltrating Lymphocyte (DeTIL-0255) Expansion and T-cell Function in Full-scale Runs By AldenMC Production / November 10, 2022
